Mutational Status of KRAS, STK11 and CDKN2A Genes as Predictors of Response to Antiangiogenic Agents in Non-small Cell Lung Cancer Patients - Cruz Castellanos, P; Rosas Alonso, R; Ozaez, I; Hernandez, I; Losantos, I; Gutierrez Sainz, L; Higuera Gomez, O; Rodriguez Antolin, C; Esteban Rodriguez, I; Ibanez de Caceres, I; De Castro Carpeno, J (Journal Of Thoracic Oncology, 2022)